Your Tier 1 supplier map may not show the dependencies that can actually stop clinical supply. David Fairnie explains how to uncover hidden vulnerabilities.
- Rare Disease Trials: Execution Risks No One Warns You About
- Undocumented Changes Break Validated Clinical Systems
- What Happens When The Clinical Forecast Changes?
- The Patient Is In The Room. Who Is Dispensing The IP?
- When Drug Supply Has A Half-Life: Radiopharmaceutical Logistics
- AI Is Moving Clinical Supply From Forecasting To Real-Time Decision-Making
- One IP Receipt Problem Is An Exception. Four Is A Process.
- Root Causes, Part 4: Why Clinical Supply Teams Are Always Firefighting
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Overcome The Supply Chain Complexities Of Vaccine Development
Explore the industry impact of rapidly evolving vaccinology, the power of next-gen science and technology, and how finding the right supply chain partner has never been more essential.
-
Key Considerations For Emerging Companies When Selecting Packaging Components
Recognizing the importance of packaging development and prioritizing its role in drug development early on can help proactively identify potential delays and overcome risks.
-
Delivering Apheresis Treatment From The USA To The UK Within 24 Hours
The goal was to perform next-day collection of temperature-sensitive tumor material for an urgent patient treatment. A flexible mitigation strategy was essential to manage short turnaround.
-
A Practical Packaging Components Checklist For Emerging Biotechs
A proactive approach to packaging development can ultimately ensure a smoother launch. Explore five key considerations when selecting components for your injectable drug product.
-
Treating Deficiencies In Employee Training And Mentorship
Investing in employee training and development is not just beneficial for the employees. It also contributes significantly to the organization’s success and competitive advantage.
-
Revolutionizing Trial Supply Management With The Power Of Free Picking
Discover the power of SmartSignals RTSM’s new free picking feature, designed to revolutionize trial supply management by optimizing efficiency and reducing costs.
-
Time, Logistics, And Manufacturing In Autologous Cell Therapy Clinical Trials
Learn how the establishment of effective guidelines and standardization relevant to cell therapy development can help to minimize delays and lead to more positive outcomes.
-
Safeguarding Cell Therapy Cryopreservation: Primary Containers
Review different aspects of container selection from the perspective of cryopreservation that are may be overlooked but critical for the quality of cell therapy drug products.
-
IRT? RTSM? What's The Difference?
What are the components of Randomization and Trial Supply Management (RTSM) and the critical role of RTSM and Interactive Response Technology (IRT) in clinical trials?
-
How Modern RTSM Platforms Are Eliminating Delays
Stop letting rigid legacy RTSM systems stall your clinical trials. Learn why manual change requests cause months of delays and how a modern, platform-based approach restores your study’s agility.
- Root Causes, Part 5: The Structural Changes Clinical Supply Needs
- Root Causes, Part 4: Why Clinical Supply Teams Are Always Firefighting
- Root Causes, Part 3: The Hidden Cost of Clinical Supply Work That Doesn't Move Trials Forward
- Root Causes, Part 2: The Translation Problem Behind Clinical Trial Execution
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.